Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA517827
Max Phase: Preclinical
Molecular Formula: C25H40N2O3
Molecular Weight: 416.61
Molecule Type: Small molecule
Associated Items:
ID: ALA517827
Max Phase: Preclinical
Molecular Formula: C25H40N2O3
Molecular Weight: 416.61
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cc1cc(C)c(NC(=O)C(C)(C)C)c2c1CCN2CCCCCCCCCC(=O)O
Standard InChI: InChI=1S/C25H40N2O3/c1-18-17-19(2)22(26-24(30)25(3,4)5)23-20(18)14-16-27(23)15-12-10-8-6-7-9-11-13-21(28)29/h17H,6-16H2,1-5H3,(H,26,30)(H,28,29)
Standard InChI Key: OQVPLOUASNKKHM-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 416.61 | Molecular Weight (Monoisotopic): 416.3039 | AlogP: 5.86 | #Rotatable Bonds: 11 |
Polar Surface Area: 69.64 | Molecular Species: ACID | HBA: 3 | HBD: 2 |
#RO5 Violations: 1 | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 4.99 | CX Basic pKa: 3.84 | CX LogP: 6.57 | CX LogD: 4.44 |
Aromatic Rings: 1 | Heavy Atoms: 30 | QED Weighted: 0.44 | Np Likeness Score: -0.59 |
1. Takahashi K, Kasai M, Ohta M, Shoji Y, Kunishiro K, Kanda M, Kurahashi K, Shirahase H.. (2008) Novel indoline-based acyl-CoA:cholesterol acyltransferase inhibitor with antiperoxidative activity: improvement of physicochemical properties and biological activities by introduction of carboxylic acid., 51 (15): [PMID:18620381] [10.1021/jm800248r] |
Source(1):